{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:26:29Z","timestamp":1737523589762,"version":"3.33.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of American College Health"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.3200\/jach.56.2.153-158","type":"journal-article","created":{"date-parts":[[2007,10,30]],"date-time":"2007-10-30T12:44:29Z","timestamp":1193748269000},"page":"153-156","source":"Crossref","is-referenced-by-count":10,"title":["Antimicrobial Resistance of Urinary Tract Isolates in Acute Uncomplicated Cystitis Among College-Aged Women: Choosing a First-Line Therapy"],"prefix":"10.1080","volume":"56","author":[{"given":"Leesa","family":"Hames","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig E.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Perfetto EM, Keating K, Merchant S, Nichols BR. Acute uncomplicated UTI and <i>E. Coli<\/i> resistance: implications for first-line empirical antibiotic therapy. <i>J Manag Care Pharm.<\/i> 2004;1017-25.","DOI":"10.18553\/jmcp.2004.10.1.17"},{"key":"E00002","unstructured":"Fourcroy JL, Gupta K, Hooton TM, et al. Managing acute uncomplicated cystitis in the era of antibiotic resistance. Medscape Web site; 2003. Available at: <a target=\"_blank\" href='http:\/\/www.medscape.com\/viewprogram\/2634'>http:\/\/www.medscape.com\/viewprogram\/2634<\/a>"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community acquired urinary tract infections. <i>Ann Intern Med.<\/i> 2001;13541-50.","DOI":"10.7326\/0003-4819-135-1-200107030-00012"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. <i>Clin Infect Dis.<\/i> 2001;3389-94.","DOI":"10.1086\/320880"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. <i>Clin Infect Dis.<\/i> 1999;29745-758.","DOI":"10.1086\/520427"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Bolon MK, Wright SB, Howard SG, Carmeli Y. The magnitude of the association between fluoroquinolone use and quinolone-resistant <i>Escherichia coli<\/i> and <i>Klebsiella pneumoniae<\/i> may be lower than previously reported. <i>Antimicrob Agents Chemother.<\/i> 2004;481934-1940.","DOI":"10.1128\/AAC.48.6.1934-1940.2004"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Zervos MJ, Hershberger E, Nicolau DP, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. <i>Clin Infect Dis.<\/i> 2003;371643-1648.","DOI":"10.1086\/379709"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant <i>Staphylococcus aureus<\/i> in hospitalized patients. <i>Emerg Infect Dis<\/i> [serial online]. November 2003. Available at: <a target=\"_blank\" href='http:\/\/www.cdc.gov\/ncidod\/EID\/vol9no11\/03-0284.htm'>http:\/\/www.cdc.gov\/ncidod\/EID\/vol9no11\/03-0284.htm<\/a>","DOI":"10.3201\/eid0911.030284"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Hooper DC. Emerging mechanisms of fluoroquinolone resistance. <i>Emerg Infect Dis<\/i> [serial online]. March-April 2001. Available at: <a target=\"_blank\" href='http:\/\/www.cdc.gov\/ncidod\/eid\/vol7no2\/hooper.htm'>http:\/\/www.cdc.gov\/ncidod\/eid\/vol7no2\/hooper.htm<\/a>","DOI":"10.3201\/eid0702.010239"},{"key":"E00010","unstructured":"Gaspari R, Bosker G. <i>Urinary Tract Infection: Risk Stratification, Clinical Evaluation, and Evidence-Based Antibiotic Therapy\u2014Year 2003 Update.<\/i> Atlanta, GA: American Health Consultants; 2003:1-22."},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Goldstein EJ, Garabedian-Ruffalo SM. Widespread use of fluoroquinolones versus emerging resistance in pneumococci. <i>Clin Infect Dis.<\/i> 2002;351505-1511.","DOI":"10.1086\/344768"},{"key":"E00012","unstructured":"Hooton TM, Levy SB. Antimicrobial resistance: a plan of action for community practice. <i>Am Fam Physician.<\/i> 2001;631087-1096."},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"MetlayJP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for Trimethoprim-sulfamethoxazole-resistant urinary tract infections. <i>J Antimicro Chemother.<\/i> 2003;51963-970.","DOI":"10.1093\/jac\/dkg146"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Karlowsky JA, Thornsberry C, Jones, ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary <i>Escherichia coli<\/i> isolates to fluoroquinolones and nitrofurantoin. <i>Clin Infect Dis.<\/i> 2003:36183-187.","DOI":"10.1086\/345754"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Karlowsky JA, Kelly LJ, Thornsberry C, Jones, ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of <i>Escherichia coli<\/i> from female outpatients in the United States. <i>Antimicrob Agents Chemother.<\/i> 2002;462540-2545.","DOI":"10.1128\/AAC.46.8.2540-2545.2002"},{"key":"E00016","unstructured":"Institute for Clinical Systems Improvement. <i>Uncomplicated Urinary Tract Infection in Women.<\/i> Bloomington, MN: Institute for Clinical Systems Improvement; 2002:1-15."},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic <i>Escherichia coli<\/i> isolates in Michigan. <i>Clin Infect Dis.<\/i> 2002;341061-1066.","DOI":"10.1086\/339491"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant <i>Escherichia Coli<\/i> clonal group. <i>N Engl J Med.<\/i> 2001;3451007-1008.","DOI":"10.1056\/NEJMoa011265"},{"key":"E00019","unstructured":"Institute for Clinical Systems Improvement. <i>Uncomplicated Urinary Tract Infection in Women.<\/i> Bloomington, MN: Institute for Clinical Systems Improvement; 2004:1-21."},{"key":"E00020","unstructured":"National Center for Education Statistics. <i>Total Fall Enrollment in Degree-Granting Institutions, by Attendance Status, Age, and Sex: Selected Years, 1970 to 2013.<\/i> National Center for Education Statistics Web site. Available at: <a target=\"_blank\" href='http:\/\/nces.ed.gov\/programs\/digest\/d03\/tables\/dt176.asp'>http:\/\/nces.ed.gov\/programs\/digest\/d03\/tables\/dt176.asp<\/a>"},{"key":"E00021","unstructured":"O'Donnell JA, Gelone SP, Abrutyn E. Selecting drug regimens for urinary tract infections: current recommendations. <i>Infect Med.<\/i> 2002;1914-22."},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. <i>Mayo Clin Proc.<\/i> 2004;791048-1054.","DOI":"10.4065\/79.8.1048"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Garrison J, Hooton TM. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women [abstract]. <i>Expert Opin Pharmacother.<\/i> 2001;21227-1237.","DOI":"10.1517\/14656566.2.8.1227"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002 [abstract]. <i>Am J Med.<\/i> 2005;118259-68.","DOI":"10.1016\/j.amjmed.2004.09.015"}],"container-title":["Journal of American College Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:50:29Z","timestamp":1737507029000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.3200\/JACH.56.2.153-158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.3200\/JACH.56.2.153-158"],"URL":"https:\/\/doi.org\/10.3200\/jach.56.2.153-158","relation":{},"ISSN":["0744-8481","1940-3208"],"issn-type":[{"type":"print","value":"0744-8481"},{"type":"electronic","value":"1940-3208"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}